Posimistiq LLC – Trademark Portfolio
Entity Type: 16
Posimistiq LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include THE PHARM, TROUBLE MARKERS, and WE PUT MENTAL HEALTH AT THE CENTER OF EVERY STORY. The owner is based in Yardley, PA.
1304 Prospect Farm Drive
Yardley, PA 19067
Showing of trademarks Trademarks
Trademark Classifications
Posimistiq LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Posimistiq LLC have?
Posimistiq LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Posimistiq LLC file in?
Posimistiq LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 9 (Computers & Electronics), Class 16 (Paper Goods). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Posimistiq LLC's most well-known trademarks?
Posimistiq LLC's registered trademark portfolio includes well-known marks such as THE PHARM, TROUBLE MARKERS, and WE PUT MENTAL HEALTH AT THE CENTER OF EVERY STORY. These are among 3 currently registered trademarks in the portfolio.
What is Posimistiq LLC's trademark registration success rate?
Posimistiq LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.